ES2177448A1 - "oxima de eritromicina a." - Google Patents
"oxima de eritromicina a."Info
- Publication number
- ES2177448A1 ES2177448A1 ES200050046A ES200050046A ES2177448A1 ES 2177448 A1 ES2177448 A1 ES 2177448A1 ES 200050046 A ES200050046 A ES 200050046A ES 200050046 A ES200050046 A ES 200050046A ES 2177448 A1 ES2177448 A1 ES 2177448A1
- Authority
- ES
- Spain
- Prior art keywords
- production
- intermediates
- erythromycin
- oxime
- macrolide production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Oxima de eritromicina A, en la que el grupo hidroxilo del grupo oxima está en forma que ha reaccionado resultante de la reacción con una base orgánica fuerte con un agente de sililación; un procedimiento para su produccion y su uso como un producto intermedio en la producción de macrólidos del tipo de eritromicina, tales como roxitromicina, azitromicina y compuestos similares.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9726992.2A GB9726992D0 (en) | 1997-12-22 | 1997-12-22 | Organic compounds |
| GB9726992 | 1997-12-22 | ||
| GB9726991 | 1997-12-22 | ||
| GBGB9726991.4A GB9726991D0 (en) | 1997-12-22 | 1997-12-22 | Organic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2177448A1 true ES2177448A1 (es) | 2002-12-01 |
| ES2177448B1 ES2177448B1 (es) | 2004-08-01 |
Family
ID=26312817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES200050046A Expired - Fee Related ES2177448B1 (es) | 1997-12-22 | 1998-12-18 | "oxima de eritromicina a.". |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2274799A (es) |
| ES (1) | ES2177448B1 (es) |
| WO (1) | WO1999032500A2 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100317907B1 (ko) * | 1998-11-24 | 2001-12-24 | 김 완 주 | 신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법 |
| KR100361397B1 (ko) * | 2000-03-15 | 2002-11-23 | 한미약품공업 주식회사 | 에리스로마이신 에이 9-오-트로필옥심 유도체를 이용한클라리스로마이신의 제조방법 |
| US7468428B2 (en) | 2004-03-17 | 2008-12-23 | App Pharmaceuticals, Llc | Lyophilized azithromycin formulation |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0222353A2 (en) * | 1985-11-12 | 1987-05-20 | Abbott Laboratories | Macrolide antibiotic derivatives |
| EP0503932A1 (en) * | 1991-03-15 | 1992-09-16 | Merck & Co. Inc. | 9-Deoxo-9(z)-hydroxy-iminoerythromycin A and O-derivatives thereof |
| WO1997036913A1 (en) * | 1996-04-02 | 1997-10-09 | Abbott Laboratories | 9-oximesilyl erythromycin a derivatives |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2534588B2 (fr) * | 1982-10-15 | 1985-09-20 | Roussel Uclaf | Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments |
-
1998
- 1998-12-18 AU AU22747/99A patent/AU2274799A/en not_active Abandoned
- 1998-12-18 ES ES200050046A patent/ES2177448B1/es not_active Expired - Fee Related
- 1998-12-18 WO PCT/EP1998/008320 patent/WO1999032500A2/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0222353A2 (en) * | 1985-11-12 | 1987-05-20 | Abbott Laboratories | Macrolide antibiotic derivatives |
| EP0503932A1 (en) * | 1991-03-15 | 1992-09-16 | Merck & Co. Inc. | 9-Deoxo-9(z)-hydroxy-iminoerythromycin A and O-derivatives thereof |
| WO1997036913A1 (en) * | 1996-04-02 | 1997-10-09 | Abbott Laboratories | 9-oximesilyl erythromycin a derivatives |
Non-Patent Citations (1)
| Title |
|---|
| Y. WATANABE et al., Journal Antibiotics, Vol. 46 (7), 1993, paginas 1163-1167. "Chemical modifications of erythromycins. A facile synthesis of clarithromycin (6-O-methylerythromycin A)". Todo el documento. * |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2177448B1 (es) | 2004-08-01 |
| AU2274799A (en) | 1999-07-12 |
| WO1999032500A3 (en) | 1999-09-02 |
| WO1999032500A2 (en) | 1999-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2279932A1 (en) | 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives | |
| IL135517A0 (en) | Chemical synthesis of 6-0-alkyl erythromycin a | |
| NZ336073A (en) | Crystal form 0 of clarithromycin as treatment for gram-positive bacteria, some gram-negative bacteria, mycoplasma and chlamidia | |
| WO2000062783A3 (en) | Ketolide antibacterials | |
| SE9301677L (sv) | Syntesmetod | |
| WO2000078773A3 (en) | Process for preparing 6-o-alkenyl-substituted erythromycin deriv atives | |
| ZA985018B (en) | 9-oxime erythromycin derivatives. | |
| IL136237A0 (en) | Process for the preparation of 6-0-methyl erythromycin a using 9-hydroxy erythromycin derivatives | |
| JP2002519014A5 (es) | ||
| IL143331A0 (en) | Novel intermediates, process for preparing macrolide antibiotic agent therefrom | |
| WO1999051616A1 (en) | 15-membered lactams ketolides with antibacterial activity | |
| ES2177448A1 (es) | "oxima de eritromicina a." | |
| FR2517311B1 (fr) | Procede chimique de synthese d'antibiotiques macrolides | |
| ES2195727A1 (es) | Un procedimiento para la obtencion de claritromicina. | |
| MX9606111A (es) | Antibioticos macrolidos. | |
| Kishi et al. | Studies on juvenimicin, a new antibiotic. II isolation, chemical characterization and structures | |
| WO2004056843A3 (en) | 10-substituted macrolide antibiotics | |
| Lartey et al. | New developments in macrolides: structures and antibacterial and prokinetic activities | |
| MXPA03010939A (es) | Un metodo de arilacion para la funcionalizacion de derivados de eritromicina de o-alilo. | |
| ES2026824A6 (es) | Procedimiento de obtencion de eritromicina 9-(0-(2-metoxietoxi)metil)oxima). | |
| KR830006430A (ko) | 탈(마이시노실옥시)타일로신의 제조방법 | |
| ES2024371A6 (es) | Procedimiento de obtencion de eritromicina 9-(0-((2-metoxietoxi)metil)oxima). | |
| WO2000040589A3 (en) | Novel derivatives from the class of oleandomycin | |
| CA2261106A1 (en) | Process for preparing erythromycin derivative, such as roxithromycin, from the corresponding oxime | |
| EP0985679B8 (en) | New hydroxy derivatives of tylosin and process for their preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EC2A | Search report published |
Date of ref document: 20021201 Kind code of ref document: A1 |
|
| FG2A | Definitive protection |
Ref document number: 2177448B1 Country of ref document: ES |
|
| FD2A | Announcement of lapse in spain |
Effective date: 20190521 |
|
| FD2A | Announcement of lapse in spain |
Effective date: 20190604 |